ABSTRACT
Trade names: Adiblastine; Adriablastine; Adriacin; Adriamycin (Bedford); Adriblatina; Doxil (Tibotec); Farmablastina; Rubex (Mead Johnson) Indications: Carcinomas, leukemias, sarcomas Category: Antibiotic, anthracycline Half-life: α phase: 0.6 hours; β phase: 16.7 hours Clinically important, potentially hazardous interactions with: aldesleukin, sorafenib
